Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| OWLS | Obook | $32.14 | -$23.41 | -0.42% | 24.2K | $4.5B | $10$90 |
| SNSE | Sensei Biotherapeutics | $13.33 | -$4.25 | -0.24% | 509.1K | $22.2M | $5$18.35 |
| EVAX | Evaxion A/s | $6.49 | -$3.11 | -0.32% | 536.4K | $60.6M | $1.2$15.5 |
| RCEL | Avita Medical | $4.08 | -$1.3 | -0.24% | 423.1K | $133.7M | $3.6$14.16 |
| ELWS | Earlyworks | $3.63 | -$1.47 | -0.29% | 222.9K | $15.4M | $1.64$10.5 |
| SLI | Standard Lithium Ltd. | $4.07 | -$1.32 | -24.49% | - | - | - |
| OTCRX | Otter Creek Long/Short Opportunity Fund - Investor Class | $11.17 | -$3.24 | -22.51% | - | - | - |
| HIMZ | Tidal Trust II - Defiance Daily Target 2x Long Hims ETF | $19.08 | -$4.02 | -0.17% | 2.6M | - | $9$57 |
| TAOP | Taoping | $2.25 | -$0.59 | -0.21% | 3.3M | $2.5M | $2.12$24.75 |
| IMAB | I-Mab | $5.68 | -$0.88 | -0.13% | 1.1M | $519.5M | $0.6$6.79 |
Related Articles
Featured Article
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?
Cory Renauer|Oct 16, 2025
Find out if the deal Omeros announced is enough of a reason to buy this stock.
2 Super Stocks That Could Go Parabolic
Josh Kohn-Lindquist|Oct 27, 2023
Transforming their niches within the healthcare industry, these businesses may offer multi-bagger potential.
This Growth Stock Could Provide Big Long-Term Gains
Jeffrey Little|Sep 1, 2022
A fertility services company aims to help people succeed in starting families.
Why This Company Still Has a Long Runway for Growth
Natalie Forbes|Jul 13, 2022
A competitive labor landscape makes this company's offerings even more attractive.
3 Innovative Growth Stocks That'll Make You Richer Through 2025
Alex Carchidi|Oct 5, 2021
Their products are better than those of their rivals, and their leads are increasing.
Why This Ultra-High-Growth Healthcare Stock Is a Buy
Jon Quast and Brian Feroldi|Sep 4, 2021
When a founder-led company is profitably chasing a huge market and having early success, the stock is worth a closer look.
2 High-Growth Stocks in the Market Today
Bradley Freeman|Feb 22, 2021
Why these two stocks are strong buys.
Here's Why Investors Should Put Progyny on Their Radar
Matt Frankel|Jan 20, 2021
This fertility stock could have serious long-term potential.
This Company Is Winning in the Fast-Growing Fertility Benefits Industry
Luis Sanchez CFA|Sep 10, 2020
Progyny provides employers with fertility benefits to help their employees build families.
AbbVie Partners With I-Mab for Cancer Drug
Jim Crumly|Sep 4, 2020
The deal could be the largest-ever out-licensing agreement by a Chinese biotech.
